曝光台 注意防骗
网曝天猫店富美金盛家居专营店坑蒙拐骗欺诈消费者
13:373-82.
Fuller J H, Shipley M J, Rose G et al. Coronary heart disease risk and impaired glucose tolerance. Lancet
1980; i:1373-6.
Gerich J F. Hypoglycaemia and counter regulation in type 2 diabetes. Lancet 2000; 356: 1946-47.
Goldgewitch C, Slama G, Papoz L et al. Hypoglycaemic reactions in 172 type 1 Diabetic Patients.
Diabetologia 1983; 24: 95-9.
ICAO Preliminary Unedited Version — March 2010 III-4A-10
Heller S, Chapman J, McLoud J, Ward J. Unreliability of reports of hypoglycaemia by diabetic patients.
Brit Med J 1995; 310:440.
Heller S. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their
duration. Diabetologia 2007; 50(6): 1140-7.
Herold K C, Polonsky K S, Cohen R M, Levy J, Douglas F. Variable deterioration in cortical function
during insulin-induced hypoglycaemia. Diabetes 1985; 34: 677-85.
Holman RR, Farmer DM, Davies MJ et al (for the 4-T Study Group). Three-Year Efficacy of Complex
Insulin Regimens in Type 2 Diabetes. The New England Journal of Medicine 2009; 361: 1736-47.
Holmes C S, Hayford J T, Gonsalez J L, Waydert J A. A survey of cognitive functioning at different
glucose levels in diabetic persons. Diabetes Care 1983; 6(2): 180-5.
Holmes C S, Koepke K M, Thompson R G. Simple versus complex impairments at three blood glucose
levels. Psychoneuroendocrinology 1986; 11:353-7.
International Expert Committee: International Expert Committee report on the roles of the A1C assay in
the diagnosis of diabetes. Diabetes Care 2009; 32:1-8.
Jennings A M, Wilson R M, Ward J D. Symptomatic hypoglycaemia in NIDDM patients treated with oral
hypoglycaemic agents. Diabetes Care 1989; 12:203-8.
Klein R, Klein B E, Moss S E, Davis M D, DeMets D L. The Wisconsin epidemiologic study of diabetic
retinopathy: III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years.
Arch Ophthalmol 1984; 102: 527-32.
Lawrence R D. I have lived for forty years the life of a diabetic patient. Diabetes 1961; 10:483-6.
MacLeod KM, Hepburn DA, Frier BM. Frequency and Morbidity of Severe Hypoglycaemia in Insulin
Treated Diabetic Patients. Diabetic Medicine 1993; 10: 238-45.
Pramming S, Thorsteinsson B, Theilgaard A, Pinner E M, Binder C. Cognitive function during
hypoglycaemia in Type 1 diabetes mellitus. Brit Med J 1986; 292: 647-50.
Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 Type I diabetic
patients. Diabet Med 1991; 8:217-22.
Stratton I M, Adler A I, Neil AW et al on behalf of the UK Prospective Diabetes Study Group. Brit Med
J 2000; 321: 405-12.
ter Braak EWMT, Appleman AMMF, Van de Lak ME et al. Clinical characteristics of Type 1 Diabetic
Patients with and without severe hypoglycaemia. Diabetes Care 2000; 23: 1467-71.
UKPDS Group. UK Prospective Diabetes Study 16: Overview of Six Years Therapy of Type 2 Diabetes
– A Progressive Disease. Diabetes 1995; 44: 1249-58.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or
insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes
(UKPDS 33). Lancet 1998; 352: 837-53.
ICAO Preliminary Unedited Version — March 2010 III-4A-11
United Kingdom prospective diabetes study (UK PDS) 13: relative efficacy of randomly allocated diet;
sulphonylurea, insulin or metformin in patients with newly diagnosed non-insulin dependent diabetes
followed for three years. Brit Med J 1995; 310:83-8.
Viberti G C, Mogensen C E, Groop L, Pauls J F. For the European Microalbuminuria Captopril Study
Group. The effect of captopril on the progression to clinical proteinuria in patients with insulin-dependent
diabetes and microalbuminuria. JAMA 1994;271:275-9.
Ward C M, Stewart A W, Cutfield R G. Hypoglycaemia in insulin dependent diabetic patients attending
an out-patients clinic. N.Z. Med J 1990: 103:339-41.
World Health Organization – Report of a WHO Consultation: Part 1 - Definition, Diagnosis and
Classification of Diabetes Mellitus. WHO Geneva 1999.
Wright AD et al 2002. UKPDS 57. www. dtu.ox.ac.uk
Wright AD, Cull CA, Macleod KM et al. Hypoglycaemia in Type 2 diabetic patients randomized to and
maintained on monotherapy with diet, sulfonylurea, metformin, or insulin for 6 years from diagnosis:
UKPDS73. Journal of Diabetes & its Complications 2006; 20(6);395-401.
————————
ICAO Preliminary Unedited Version — November 2009 III-4A2-1
Appendix 2
PROTOCOL DEVELOPMENT FOR CERTIFICATION
OF APPLICANTS WITH TYPE 2 DIABETES
Achieving and sustaining near normal glycaemia is a central target in the management of patients with
both Type 1 and Type 2 diabetes mellitus whose microvascular complications are then reduced 1, 2.
中国航空网 www.aero.cn
航空翻译 www.aviation.cn
本文链接地址：
Manual of Civil Aviation Medicine 1(141)
